Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
Authors:
- Amit K. GoyalAGAmit K. Goyal
- Prem N. GuptaPGPrem N. Gupta
- Neeraj MishraNMNeeraj Mishra
- Suresh P. VyasSVSuresh P. Vyas
- 1 April 2008
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 354 (1-2) , 235-241
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against Hepatitis BImmunology Letters, 2005
- Effective nasal influenza vaccine delivery using chitosanVaccine, 2005
- Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in miceEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Intranasal Gene Transfer by Chitosan–DNA Nanospheres Protects BALB/c Mice Against Acute Respiratory Syncytial Virus InfectionHuman Gene Therapy, 2002
- Nasal vaccinesAdvanced Drug Delivery Reviews, 2001
- The Preferential Induction of a Th1 Immune Response by DNA-Based Immunization Is Mediated by the Immunostimulatory Effect of Plasmid DNACellular Immunology, 1997
- DNA VACCINESAnnual Review of Immunology, 1997
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Host Defense Mechanisms at Mucosal SurfacesAnnual Review of Microbiology, 1981
- Hepatitis B VaccineNew England Journal of Medicine, 1980